Toward a chemical vaccine for malaria
(Source: ScienceNOW)
Source: ScienceNOW - December 6, 2018 Category: Science Authors: Phillips, M. A., Goldberg, D. E. Tags: perspective Source Type: news

Africa: Novel Approach Brings African Scientists Closer to a Malaria Vaccine
[The Conversation Africa] Malaria is still a major problem in Africa. There are over 200 million clinical cases each year and approximately half a million deaths. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - November 14, 2018 Category: Infectious Diseases Source Type: news

Cardiac experts urge patients to get flu vaccine
Vaccine can cut risk of heart and circulatory deaths by 24% Related items fromOnMedica HIV therapy helps protect men from Hep B infection Malaria cases rise sharply BMJ report questions swine flu jab transparency NICE urges wider uptake of flu vaccination Boys will receive HPV vaccine (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 2, 2018 Category: UK Health Source Type: news

A study identifies new markers associated with protection by the RTS,S malaria vaccine
(Barcelona Institute for Global Health (ISGlobal)) Protection conferred by the RTS,S malaria vaccine depends greatly on the amount and subclass of antibodies generated upon vaccination, and on previous exposure levels to the parasite, according to a study led by ISGlobal, an institution supported by 'la Caixa' Foundation. The results, published in BMC Medicine, shed new light on the mechanisms by which RTS,S confers protection and provide the basis for developing more efficacious vaccines. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 30, 2018 Category: Infectious Diseases Source Type: news

Q & A on the investigational vaccine candidate M72/AS01E
M72/AS01E is a subunit vaccine comprised of an immunogenic fusion protein (M72) derived from two Mycobacterium tuberculosis (M.tb) antigens (MTB32A and MTB39A), and the GlaxoSmithKline (GSK) proprietary adjuvant AS01E. AS01E is the same adjuvant used in Shingrix GSK vaccine, as well as in the new malaria vaccine RTS,S/AS01E. The M72/AS01E vaccine candidate is being developed by the pharmaceutical company GlaxoSmithKline, in partnership with AERAS. AERAS is a not for profit organization based in the US, aimed at supporting tuberculosis vaccine research, funded by the Bill and Melinda Gates foundation, the UK Department for ...
Source: WHO Feature Stories - October 10, 2018 Category: International Medicine & Public Health Tags: tuberculosis [subject], tb Source Type: news

Vaccinating humans to protect mosquitoes from malaria
(University at Buffalo) For decades, scientists have been trying to develop a vaccine that prevents mosquitoes from spreading malaria among humans. This unique approach -- in which immunized humans transfer anti-malarial proteins to mosquitoes when bitten -- is called a transmission-blocking vaccine (TBV). A new biotech advancement moves us closer to this goal. If successful, it could help reduce the spread of the disease, which kills more than 400,000 people annually. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 8, 2018 Category: Infectious Diseases Source Type: news

Bill Gates Talks to TIME About a Coming ‘Third Wave’ of Development in Africa
There’s a very big difference between simple and easy—especially when it comes to global health. It’s simple to eradicate polio—just get all children are vaccinated. It’s simple to reduce nighttime malaria infections—make sure everyone in malaria-endemic areas sleeps under a bed net. But none of that is easy. The tension between simple and easy is at play when it comes to eradicating poverty in the developing world too, as the Bill & Melinda Gates Foundation makes clear in its second annual Goalkeepers Data Report. In a conversation with TIME, Bill Gates points to two recent waves of...
Source: TIME: Health - September 21, 2018 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized onetime public health Source Type: news

Malaria treatment: Is there a vaccine for Malaria?
MALARIA is currently plaguing the Indonesian tourist island of Lombok, where a recent earthquake devastated the country, paving the way for a potentially deadly Malaria outbreak. Is there a vaccine for Malaria? (Source: Daily Express - Health)
Source: Daily Express - Health - September 19, 2018 Category: Consumer Health News Source Type: news

Global Health: Vaccines Against H.I.V., Malaria and Tuberculosis Unlikely, Study Says
Unless the $3 billion spent annually on research triples, the world may not be able to invent vaccines or rapid cures for many ills of the poor. (Source: NYT Health)
Source: NYT Health - September 7, 2018 Category: Consumer Health News Authors: DONALD G. McNEIL Jr. Tags: Vaccination and Immunization Tests (Medical) Tuberculosis Acquired Immune Deficiency Syndrome Malaria Third World and Developing Countries Duke University Gates, Bill and Melinda, Foundation Fauci, Anthony S Source Type: news

Effective TB, HIV, malaria vaccines missing from pipeline
(Duke University) Many of the vaccines critically needed to fight the world's most prevalent infectious diseases are not likely to be developed. A financial modeling study of 538 candidate products for 35 neglected diseases estimated the costs and likelihood that each would progress to a product launch. Using a new tool known as Portfolio-to-Impact (P2I), the researchers found only 128 of those candidates would make it through the drug development pipeline. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 4, 2018 Category: International Medicine & Public Health Source Type: news

Health systems in low- and middle-income countries not prepared to diagnose and treat common diseases
Cardiovascular diseases, chronic respiratory diseases and diabetes are among the leading causes of death worldwide. A new UCLA study has found that Bangladesh, Haiti, Malawi, Nepal and Tanzania each has fewer than five health facilities that can provide the full suite of supplies and equipment, trained staff and medication that are needed to properly diagnose and treat all three diseases.“These five countries, paralleling global trends, are seeing an increase in the number of people with these noncommunicable diseases,” said the lead author, Corrina Moucheraud, assistant professor of health policy and managemen...
Source: UCLA Newsroom: Health Sciences - August 6, 2018 Category: Universities & Medical Training Source Type: news

Yale researchers identify target for novel malaria vaccine
Researchers have created a vaccine that protects against malaria infection in mouse models, paving the way for the development of a human vaccine. (Source: Yale Science and Health News)
Source: Yale Science and Health News - July 13, 2018 Category: Universities & Medical Training Source Type: news

Yale researchers identify target for novel malaria vaccine
(Yale University) A Yale-led team of researchers have created a vaccine that protects against malaria infection in mouse models, paving the way for the development of a human vaccine that works by targeting the specific protein that parasites use to evade the immune system. The study was published by Nature Communications. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 13, 2018 Category: International Medicine & Public Health Source Type: news

Certain antibodies against a sugar are associated with malaria protection
(Barcelona Institute for Global Health (ISGlobal)) Certain type of antibodies againstα-Gal- a carbohydrate expressed by many organisms including the malaria parasite- could protect against malaria, according to a new study led by ISGlobal, an institution supported by 'la Caixa' Foundation. The results, published in Scientific Reports, indicate that a-Gal is an interesting candidate to include in future vaccines against malaria and other infectious diseases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 9, 2018 Category: International Medicine & Public Health Source Type: news

Research suggests new vaccine candidates for malaria
(American Society for Microbiology) Researchers have shown that higher levels of Plasmodium falciparum antibodies are protective against severe malaria in children living in Papua New Guinea. Children who have higher levels of antibodies to a specific short amino acid sequence in the malaria parasite, P. falciparum, have much lower rates of clinical and severe malaria. This amino acid sequence, an antigen, is similar among P. falciparum strains elsewhere in the world, suggesting that this antigen would make a good target for a malaria vaccine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 6, 2018 Category: International Medicine & Public Health Source Type: news

New & Resurgent Infectious Diseases Can Have Far-reaching Economic Repercussions
DAVID E. BLOOM is the Clarence James Gamble Professor of Economics and Demography, DANIEL CADARETTE is a research assistant, and JP SEVILLA is a research associate, all at Harvard University’s T.H. Chan School of Public Health.By David E. Bloom, Daniel Cadarette and JP SevillaWASHINGTON DC, Jul 3 2018 (IPS)Infectious diseases and associated mortality have abated, but they remain a significant threat throughout the world.We continue to fight both old pathogens, such as the plague, that have troubled humanity for millennia and new pathogens, such as human immunodeficiency virus (HIV), that have mutated or spilled over ...
Source: IPS Inter Press Service - Health - July 3, 2018 Category: International Medicine & Public Health Authors: David E. Bloom and JP Sevilla Tags: Active Citizens Development & Aid Economy & Trade Global Headlines Health TerraViva United Nations Source Type: news

A promising new tool to measure antibodies against malaria
(Barcelona Institute for Global Health (ISGlobal)) Antibodies against multiple Plasmodium falciparum proteins (or antigens) can be measured using a simple, accurate and reproducible assay that requires very small amounts of blood. In a series of recently published articles, a team led by ISGlobal -- an institution supported by 'la Caixa' Foundation -- reports the development and optimisation of several 'quantitative suspension array' assays (qSAT) that could help assess natural and vaccine-induced responses to malaria and other parasites. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 3, 2018 Category: Infectious Diseases Source Type: news

How a Drug For Pets May Help Prevent Zika and Malaria
Diseases spread by pests like mosquitoes and fleas remain global health problems. To prevent transmission, public health strategy has largely focused on using insecticides or bed nets. Vaccines are also under development for diseases like Zika, but few are approved for use. Now, a new study suggests that medicines already used for pets to protect against fleas and ticks could offer similar protection for humans. In the report, published Monday in the journal Proceedings of the National Academy of Sciences, researchers at the nonprofit drug discovery institute Calibr and TropIQ Health Sciences report that drugs called isoxa...
Source: TIME: Health - July 2, 2018 Category: Consumer Health News Authors: Alexandra Sifferlin Tags: Uncategorized healthytime Innovation Health public health Source Type: news

How a Drug For Pets May Help Prevent Zika and Malaria
Diseases spread by pests like mosquitoes and fleas remain global health problems. To prevent transmission, public health strategy has largely focused on using insecticides or bed nets. Vaccines are also under development for diseases like Zika, but few are approved for use. Now, a new study suggests that medicines already used for pets to protect against fleas and ticks could offer similar protection for humans. In the report, published Monday in the journal Proceedings of the National Academy of Sciences, researchers at the nonprofit drug discovery institute Calibr and TropIQ Health Sciences report that drugs called isoxa...
Source: TIME: Science - July 2, 2018 Category: Science Authors: Alexandra Sifferlin Tags: Uncategorized healthytime Innovation Health public health Source Type: news

Nigeria:Could a New Typhoid Vaccine End the Most Misdiagnosed Disease in Nigeria?
[Nigeria Health Watch] "Typhoid fever" has long been recognized as one of the most diagnosed diseases in Nigeria. The challenge is that when diagnosed properly, typhoid fever is actually a life-threatening infection caused by the bacterium Salmonella Typhi. It is usually spread through contaminated food or water, and symptoms, including prolonged fever, fatigue, headache, nausea, and abdominal pain are very similar to those of the most common cause of fever in Nigeria -- malaria. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 28, 2018 Category: African Health Source Type: news

First malaria-human contact mapped with Nobel Prize-winning technology
(Walter and Eliza Hall Institute) Melbourne scientists have taken a significant step toward developing a new vaccine for malaria, revealing for the first time an 'atomic-scale' blueprint of how the parasite invades human cells.Using the Nobel Prize-winning technology cryo-EM (cryo-electron microscopy), the researchers mapped the previously hidden first contact between Plasmodium vivax malaria parasites and young red blood cells they invade to begin the parasites' spread throughout the body. The discovery was published today in Nature. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 27, 2018 Category: Infectious Diseases Source Type: news

Killer immune cells that halt malaria could hold key to new vaccines
(eLife) Scientists have revealed that immune cells called natural killer (NK) cells may play a key role in ridding the body of malaria-infected blood cells, a study in eLife reports. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 26, 2018 Category: Infectious Diseases Source Type: news

Combining different malaria vaccines could reduce cases by 91 percent
Using two experimental anti-malarial vaccines can greatly reduce the number of malaria infections in animal studies, according to a research team that includes MRC scientists. (Source: Medical Research Council General News)
Source: Medical Research Council General News - June 20, 2018 Category: Research Source Type: news

Combining different malaria vaccines could reduce cases by 91 percent
(Imperial College London) Using two experimental anti-malarial vaccines, which work in different ways, can greatly reduce the number of malaria infections in animal studies. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 19, 2018 Category: International Medicine & Public Health Source Type: news

How Community Health Workers Could Save 30 Million Lives By 2030
When Dr. Raj Panjabi talks about starting his nonprofit, Last Mile Health, he describes being motivated by both love and outrage. At nine years old, Panjabi had to flee his home in Liberia to escape civil war; he and his family relocated to the U.S. When Panjabi returned to his home country as a medical student, he discovered there were only 51 doctors left to serve the country’s four million people. As a result, many residents were dying from treatable conditions, especially in rural areas, simply because they lived too far away from doctors and hospitals. “We’ve kind of written these communities off as ...
Source: TIME: Health - June 11, 2018 Category: Consumer Health News Authors: TIME Staff Tags: Uncategorized community health workers Dr. Raj Panjabi ebola Health Care Last Mile Health medicine TIME 100 TIME 100 x WeWork Speaker Series Zika Source Type: news

Bill And Melinda Gates Start A Nonprofit Biotech In Boston
The Bill& Melinda Gates Medical Research Institute, which is holding an event today to show off its plans, will aim to develop new medicines and vaccines for malaria, tuberculosis, and diarrhea, which together account for 2.6 million deaths a year globally, many of them in children. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 7, 2018 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Source Type: news

Malaria: Cooperating antibodies enhance immune response
In this study, the researchers discovered a previously unnoticed characteristic of antibodies against the malaria parasite: They can cooperate with each other, thus binding even stronger to the pathogens and improving the immune response. The results, now published in Science, are expected to help develop a more effective vaccine against the disease. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 7, 2018 Category: Infectious Diseases Source Type: news

Rwanda:Hygiene is the Primary Vaccine Against Child Disease - Minister Gashumba
[New Times] The Minister for Health, Dr Diane Gashumba, has urged members of the public to uphold hygiene, starting from the household, in a bid to fight malaria and other poor hygiene-induced diseases. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 17, 2018 Category: African Health Source Type: news

Major enhancement to in vitro testing of human liver-stage malaria
(University of South Florida (USF Health)) Researchers have developed an enhanced method to conducting liver-stage malaria research in vitro, allowing them to more quickly screen preclinical drugs and vaccines than current techniques. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 9, 2018 Category: International Medicine & Public Health Source Type: news

How Imams, Royalty and Family Celebrations are Wiping Out Polio in Nigeria
Ramlatu Musaa never met the Emir of Kano State in northern Nigeria. Of course, Ramlatu Musaa hasn’t met a lot of people. She’s only about a week old, born in Kano on April 29, 2018, and yet in some ways, the Emir may have helped saved her life. Two years ago, the polio vaccine was available in Nigeria, but it was still frequently rejected by families. Stray rumors continued to circulate that it was unsafe, able to sicken children and render them infertile. So before one of that year’s national vaccination campaigns began, the Emir—a hereditary leader descended from a ruling family—appeared at ...
Source: TIME: Health - May 7, 2018 Category: Consumer Health News Authors: Jeffrey Kluger / Kano Tags: Uncategorized healthytime public health Source Type: news

How Imams, Royalty and Family Celebrations are Wiping Out Polio in Nigeria
Ramlatu Musaa never met the Emir of Kano State in northern Nigeria. Of course, Ramlatu Musaa hasn’t met a lot of people. She’s only about a week old, born in Kano on April 29, 2018, and yet in some ways, the Emir may have helped saved her life. Two years ago, the polio vaccine was available in Nigeria, but it was still frequently rejected by families. Stray rumors continued to circulate that it was unsafe, able to sicken children and render them infertile. So before one of that year’s national vaccination campaigns began, the Emir—a hereditary leader descended from a ruling family—appeared at ...
Source: TIME: Science - May 7, 2018 Category: Science Authors: Jeffrey Kluger / Kano Tags: Uncategorized healthytime public health Source Type: news

Discovery of Malaria Parasite Survival Genes Offers New Targets Discovery of Malaria Parasite Survival Genes Offers New Targets
Scientists have identified the core genes that are essential for the deadliest malaria parasite to survive, revealing new targets for drugs or vaccines to fight the potentially deadly disease they cause in people.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 4, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Discovery of malaria parasite survival genes offers new targets
LONDON (Reuters) - Scientists have identified the core genes that are essential for the deadliest malaria parasite to survive, revealing new targets for drugs or vaccines to fight the potentially deadly disease they cause in people. (Source: Reuters: Health)
Source: Reuters: Health - May 3, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Researchers unravel genomic mystery of malaria's deadliest parasite
(University of South Florida (USF Health)) Antimalarial drugs and vaccines are expected to be far more superior with the uncovering of Plasmodium falciparum's full genome, the parasite that makes malaria so deadly. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 3, 2018 Category: Infectious Diseases Source Type: news

Uncovering the essential genes of the human malaria parasite Plasmodium falciparum by saturation mutagenesis
Severe malaria is caused by the apicomplexan parasite Plasmodium falciparum. Despite decades of research, the distinct biology of these parasites has made it challenging to establish high-throughput genetic approaches to identify and prioritize therapeutic targets. Using transposon mutagenesis of P. falciparum in an approach that exploited its AT-rich genome, we generated more than 38,000 mutants, saturating the genome and defining mutability and fitness costs for over 87% of genes. Of 5399 genes, our study defined 2680 genes as essential for optimal growth of asexual blood stages in vitro. These essential genes are associ...
Source: ScienceNOW - May 3, 2018 Category: Science Authors: Zhang, M., Wang, C., Otto, T. D., Oberstaller, J., Liao, X., Adapa, S. R., Udenze, K., Bronner, I. F., Casandra, D., Mayho, M., Brown, J., Li, S., Swanson, J., Rayner, J. C., Jiang, R. H. Y., Adams, J. H. Tags: Microbiology, Online Only r-articles Source Type: news

Scripps Research scientists receive $12 million for malaria and flu vaccine research
(Scripps Research Institute) With the new funding from the Gates Foundation, the Scripps Research team will expand their studies of broadly neutralizing antibodies. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 2, 2018 Category: Infectious Diseases Source Type: news

Global Health: Tick and Mosquito Infections Spreading Rapidly, C.D.C. Finds
Rates of Lyme, Zika and exotic new diseases are soaring. Federal officials blame hotter weather, jet travel, forested suburbs and slow vaccine development. (Source: NYT Health)
Source: NYT Health - May 1, 2018 Category: Consumer Health News Authors: DONALD G. McNEIL Jr. Tags: Ticks (Insects) Mosquitoes Chikungunya Virus Global Warming Lyme Disease Zika Virus Malaria Rocky Mountain Spotted Fever St Maarten (Caribbean) United States Source Type: news

Global Health: Ticks and Mosquito Infections Spreading Rapidly, C.D.C. Finds
Americans are getting Zika, dengue and Lyme diseases in increasing numbers. Warming weather and a lack of vaccines are among the causes. (Source: NYT Health)
Source: NYT Health - May 1, 2018 Category: Consumer Health News Authors: DONALD G. McNEIL Jr. Tags: Ticks (Insects) Mosquitoes Chikungunya Virus Global Warming Lyme Disease Zika Virus Malaria Rocky Mountain Spotted Fever St Maarten (Caribbean) United States Source Type: news

Analysis links US government global health R & D funding to jobs, economic benefits across states
The Trump Administration's proposal to slash funding to fight global health threats like malaria, Ebola, and HIV/AIDS could cost states thousands of jobs and millions of dollars in economic investment and put the health of residents at risk, according to a new state-by-state analysis released today on Capitol Hill by the Global Health Technologies Coalition (GHTC). This first-of-its-kind analysis quantifies how federal funding to create vaccines and treatments to combat deadly global diseases also benefits American states. (Source: World Pharma News)
Source: World Pharma News - May 1, 2018 Category: Pharmaceuticals Tags: Featured Development Research and Development Source Type: news

Analysis links US government global health R & D funding to jobs, economic benefits across states
(Global Health Technologies Coalition) The Trump Administration's proposal to slash funding to fight global health threats like malaria, Ebola, and HIV/AIDS could cost states thousands of jobs and millions of dollars in economic investment and put the health of residents at risk, according to a new state-by-state analysis released today by the Global Health Technologies Coalition. This first-of-its-kind analysis quantifies how federal funding to create vaccines and treatments to combat deadly global diseases also benefits American states. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 1, 2018 Category: Infectious Diseases Source Type: news

Tanzania:Malaria Vaccines Show Positive Signs
[Citizen] Dar es Salaam -Hope of getting a malaria vaccine is increasing following the announcement by Ifakara Health Institute (IHI) on Wednesday that two of its projects had shown positive results. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 26, 2018 Category: Infectious Diseases Source Type: news

Fresh search for a vaccine against malaria parasite Plasmodium vivax
Hundreds of millions of people each year are infected with Plasmodium vivax, the most widespread form of malaria worldwide. An EU-funded project is tackling the mosquito-borne parasite, leading cutting-edge research efforts to accelerate the development of effective vaccines. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - April 25, 2018 Category: Research Source Type: news

An effective vaccine for the deadliest malaria
EU-funded researchers are using the latest vaccine technologies and antigen discovery tools to develop a multi-stage, multi-antigen vaccine against Plasmodium falciparum, the parasite responsible for the deadliest form of malaria. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - April 25, 2018 Category: Research Source Type: news

Malaria vaccine pilot steers past final delays
Health officials in Ghana, Kenya and Malawi have to get the right systems in place (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - April 17, 2018 Category: Pharmaceuticals Source Type: news

Nigeria:Scientists Near Effective Malaria Vaccine, Solve 20-Year-Old Mystery
[Guardian] Ahead of the World Malaria Day (WMD), April 25, scientists across the globe have recorded major breakthroughs in efforts to eradicate and eliminate the female anopheles mosquito-borne disease. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 12, 2018 Category: Infectious Diseases Source Type: news

Ruth Nussenzweig, Who Pursued Malaria Vaccine, Dies at 89
Dr. Nussenzweig ’ s research into one of the world ’ s most deadly diseases laid the groundwork for an approach once thought beyond reach. (Source: NYT Health)
Source: NYT Health - April 11, 2018 Category: Consumer Health News Authors: NEIL GENZLINGER Tags: Malaria New York University Langone Medical Center Deaths (Obituaries) Research Nussenzweig, Ruth Source Type: news

Study explores new strategy to develop a malaria vaccine
The study looks at a Yale-developed serum that attacks a protein in the saliva of malaria parasite-infected mosquitos, rather than the parasite itself. (Source: Yale Science and Health News)
Source: Yale Science and Health News - April 11, 2018 Category: Universities & Medical Training Source Type: news

Study explores new strategy to develop a malaria vaccine
(Yale University) A serum developed by Yale researchers reduces infection from malaria in mice, according to a new study. It works by attacking a protein in the saliva of the mosquitoes infected with the malaria parasite rather than the parasite itself. If the novel approach proves effective in further studies, it could potentially be used to enhance existing malaria vaccines, the researchers said. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 11, 2018 Category: Infectious Diseases Source Type: news

20-year-old mystery of malaria vaccine target solved
(Wellcome Trust Sanger Institute) The human piece of a malaria infection puzzle has been revealed for the first time, solving a long-standing mystery. A protein displayed on the surface of malaria parasites called 'TRAP' is a high-priority vaccine target, but how it interacts with human host cells has remained a puzzle. Wellcome Sanger Institute scientists have discovered a receptor protein on the surface of human cells that the TRAP protein interacts with as it navigates through the body. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 9, 2018 Category: Infectious Diseases Source Type: news

$3.2 million grant funds development of new malaria vaccine
(University of Florida) The Global Health Innovative Technology Fund has awarded the University of Florida and partners in the United States and Japan $3.2 million to advance a promising vaccine to prevent transmission of malaria. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 29, 2018 Category: Infectious Diseases Source Type: news